BACE1, an enzyme that cleaves Amyloid Precursor Protein (APP) and produces Amyloid β (Aβ), is a promising target for Alzheimer's Disease (AD) treatment. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.